Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.

Previous studies have reported that microbubbles bearing targeting ligands to molecular markers of angiogenesis can be successfully detected by ultrasound imaging in various animal models of solid cancer. In the present study, we sought to investigate the activity of microbubbles targeted to vascular endothelial growth factor receptor 2 (VEGFR2) in an orthotopic model of renal cell carcinoma (RCC). Microbubbles conjugated to an anti-VEGFR2 antibody (MBV) were compared with microbubbles conjugated to an isotype control antibody (MBC) or naked microbubbles (MBN). An orthotopic mouse model of human RCC was established by surgically implanting an established tumor within the renal capsule in mice. Tumor growth and blood flow were verified by B-mode and color Doppler ultrasound imaging. VEGFR2 expression within the tumor and renal parenchyma was detected by immunohistochemistry. The duration of contrast enhancement of MBV was much longer than those of MBN and MBC when assessed over 10 min. The baseline-subtracted contrast intensity within the tumor was higher for MBV than for MBC and MBN (p < 0.01). Additionally, the contrast intensity for MBV was significantly higher in the tumor region than in normal parenchyma (p < 0.01). Microbubbles targeting VEGFR2 exhibit suitable properties for imaging angiogenesis in orthotopic models of renal cell carcinoma, with potential applications in life science research and clinical medicine.

[1]  François Tranquart,et al.  Ultrasound Molecular Imaging of VEGFR2 in a Rat Prostate Tumor Model Using BR55 , 2010, Investigative radiology.

[2]  Hairong Zheng,et al.  Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[3]  M. Gordon,et al.  Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma , 2008 .

[4]  Isabelle Tardy,et al.  BR55: A Lipopeptide-Based VEGFR2-Targeted Ultrasound Contrast Agent for Molecular Imaging of Angiogenesis , 2010, Investigative radiology.

[5]  Alexander L. Klibanov,et al.  Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications , 2006, Investigative radiology.

[6]  Kumar Sharma,et al.  Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent , 2011, Investigative radiology.

[7]  K. Ley,et al.  scVEGF Microbubble Ultrasound Contrast Agents: A Novel Probe for Ultrasound Molecular Imaging of Tumor Angiogenesis , 2010, Investigative radiology.

[8]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[9]  Sanjiv S Gambhir,et al.  US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. , 2008, Radiology.

[10]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[11]  H. Miyake,et al.  Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib. , 2013, Urologic oncology.

[12]  M. Karno,et al.  Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.

[13]  Sanjiv S. Gambhir,et al.  How molecular imaging is speeding up antiangiogenic drug development , 2006, Molecular Cancer Therapeutics.

[14]  Rolf A. Brekken,et al.  Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature , 2007, Clinical Cancer Research.

[15]  John C Gore,et al.  Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression Using Targeted Contrast‐Enhanced High‐Frequency Ultrasonography , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[16]  Sanjiv S Gambhir,et al.  Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. , 2008, Radiology.

[17]  J. Tonn,et al.  Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. , 2002, The Journal of clinical investigation.

[18]  T. Habuchi,et al.  Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma. , 2001, The Tohoku journal of experimental medicine.

[19]  Apurva A Desai,et al.  Sorafenib in advanced clear-cell renal-cell carcinoma. , 2007, The New England journal of medicine.

[20]  K. Sharma,et al.  In vivo validation and 3D visualization of broadband ultrasound molecular imaging. , 2013, American journal of nuclear medicine and molecular imaging.

[21]  J. Yeh,et al.  A Comparative Evaluation of Ultrasound Molecular Imaging, Perfusion Imaging, and Volume Measurements in Evaluating Response to Therapy in Patient-Derived Xenografts , 2013, Technology in cancer research & treatment.

[22]  I. Fidler,et al.  Orthotopic implantation is essential for the selection, growth and metastasis of human real cell cancer in nude mice , 1990, Cancer and Metastasis Reviews.

[23]  M. Shibuya.  Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. , 2006, Journal of biochemistry and molecular biology.

[24]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  F. Stuart Foster,et al.  Microultrasound Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 in a Mouse Model of Tumor Angiogenesis , 2007, Molecular imaging.

[26]  M. Jinzaki,et al.  Double-Phase Helical CT of Small Renal Parenchymal Neoplasms: Correlation with Pathologic Findings and Tumor Angiogenesis , 2000, Journal of computer assisted tomography.

[27]  Fuminori Moriyasu,et al.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. , 2007, Ultrasound in medicine & biology.

[28]  R. Motzer,et al.  Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial , 2011, The Lancet.

[29]  H. Jun,et al.  Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model. , 2010, Academic radiology.

[30]  Sanjiv S. Gambhir,et al.  Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides , 2010, Journal of Nuclear Medicine.

[31]  B. Rini,et al.  Renal cell carcinoma , 2009, The Lancet.

[32]  S. Kaul,et al.  Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression , 2005, Circulation.

[33]  Y. Yamashita,et al.  Small renal cell carcinoma: pathologic and radiologic correlation. , 1992, Radiology.